Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Balance Sheet
Balance Sheet Decomposition
Lepu Medical Technology Beijing Co Ltd
Current Assets | 8.7B |
Cash & Short-Term Investments | 3.8B |
Receivables | 2.3B |
Other Current Assets | 2.7B |
Non-Current Assets | 16.3B |
Long-Term Investments | 2.8B |
PP&E | 5B |
Intangibles | 6.6B |
Other Non-Current Assets | 2B |
Balance Sheet
Lepu Medical Technology Beijing Co Ltd
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
506
|
1 864
|
1 910
|
2 204
|
2 169
|
1 792
|
2 395
|
3 685
|
5 323
|
4 100
|
|
Cash |
0
|
0
|
1
|
1
|
2
|
2
|
1
|
3 684
|
5 309
|
4 100
|
|
Cash Equivalents |
506
|
1 864
|
1 909
|
2 203
|
2 167
|
1 790
|
2 394
|
1
|
13
|
0
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
10
|
21
|
0
|
277
|
275
|
|
Total Receivables |
882
|
1 304
|
1 437
|
1 841
|
2 337
|
2 488
|
2 383
|
2 006
|
2 271
|
2 035
|
|
Accounts Receivables |
817
|
1 183
|
1 219
|
1 632
|
1 970
|
2 167
|
2 100
|
1 661
|
1 909
|
1 753
|
|
Other Receivables |
65
|
121
|
218
|
209
|
367
|
321
|
283
|
345
|
362
|
282
|
|
Inventory |
250
|
519
|
574
|
702
|
786
|
1 005
|
1 424
|
1 939
|
2 267
|
2 289
|
|
Other Current Assets |
77
|
127
|
222
|
412
|
414
|
340
|
355
|
518
|
612
|
626
|
|
Total Current Assets |
1 715
|
3 815
|
4 143
|
5 159
|
5 706
|
5 634
|
6 577
|
8 147
|
10 749
|
9 325
|
|
PP&E Net |
728
|
1 039
|
1 213
|
1 527
|
2 052
|
2 353
|
2 860
|
3 726
|
4 537
|
5 252
|
|
PP&E Gross |
728
|
1 039
|
1 213
|
1 527
|
2 052
|
2 353
|
2 860
|
3 726
|
4 537
|
5 252
|
|
Accumulated Depreciation |
204
|
478
|
645
|
769
|
892
|
1 056
|
1 244
|
1 490
|
1 833
|
2 092
|
|
Intangible Assets |
214
|
606
|
714
|
1 536
|
1 630
|
2 009
|
1 900
|
2 110
|
2 358
|
2 679
|
|
Goodwill |
720
|
1 799
|
2 069
|
2 163
|
2 162
|
2 719
|
2 772
|
3 273
|
3 331
|
3 504
|
|
Note Receivable |
8
|
29
|
152
|
90
|
217
|
171
|
23
|
11
|
8
|
3
|
|
Long-Term Investments |
178
|
370
|
1 105
|
2 165
|
3 123
|
2 719
|
3 650
|
3 053
|
2 987
|
3 410
|
|
Other Long-Term Assets |
268
|
73
|
105
|
151
|
224
|
322
|
376
|
378
|
514
|
849
|
|
Other Assets |
720
|
1 799
|
2 069
|
2 163
|
2 162
|
2 719
|
2 772
|
3 273
|
3 331
|
3 504
|
|
Total Assets |
3 830
N/A
|
7 730
+102%
|
9 500
+23%
|
12 791
+35%
|
15 113
+18%
|
15 926
+5%
|
18 157
+14%
|
20 699
+14%
|
24 484
+18%
|
25 022
+2%
|
|
Liabilities | |||||||||||
Accounts Payable |
105
|
276
|
319
|
465
|
650
|
738
|
755
|
1 135
|
1 338
|
861
|
|
Accrued Liabilities |
44
|
86
|
106
|
162
|
201
|
188
|
249
|
310
|
455
|
211
|
|
Short-Term Debt |
249
|
1 165
|
1 325
|
1 667
|
2 617
|
2 401
|
2 065
|
948
|
790
|
1 379
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
142
|
905
|
1 353
|
1 092
|
250
|
1 560
|
498
|
|
Other Current Liabilities |
120
|
476
|
285
|
781
|
697
|
430
|
651
|
690
|
1 181
|
809
|
|
Total Current Liabilities |
517
|
2 003
|
2 035
|
3 217
|
5 069
|
5 111
|
4 812
|
3 332
|
5 323
|
3 759
|
|
Long-Term Debt |
0
|
310
|
1 353
|
2 417
|
3 231
|
2 468
|
2 338
|
4 008
|
2 401
|
3 373
|
|
Deferred Income Tax |
0
|
47
|
65
|
88
|
91
|
207
|
324
|
265
|
206
|
198
|
|
Minority Interest |
150
|
532
|
479
|
598
|
226
|
522
|
665
|
800
|
1 224
|
1 521
|
|
Other Liabilities |
20
|
32
|
34
|
42
|
133
|
135
|
146
|
820
|
184
|
195
|
|
Total Liabilities |
687
N/A
|
2 923
+325%
|
3 966
+36%
|
6 361
+60%
|
8 752
+38%
|
8 444
-4%
|
8 284
-2%
|
9 225
+11%
|
9 338
+1%
|
9 046
-3%
|
|
Equity | |||||||||||
Common Stock |
812
|
872
|
1 782
|
1 782
|
1 782
|
1 782
|
1 805
|
1 805
|
1 881
|
1 881
|
|
Retained Earnings |
1 579
|
1 986
|
2 526
|
3 251
|
4 243
|
5 840
|
7 326
|
8 706
|
10 254
|
10 928
|
|
Additional Paid In Capital |
753
|
1 951
|
1 144
|
1 144
|
91
|
2
|
959
|
984
|
3 243
|
3 465
|
|
Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
132
|
|
Treasury Stock |
0
|
0
|
0
|
0
|
96
|
254
|
254
|
364
|
356
|
431
|
|
Other Equity |
1
|
3
|
82
|
253
|
342
|
113
|
37
|
344
|
124
|
266
|
|
Total Equity |
3 143
N/A
|
4 807
+53%
|
5 534
+15%
|
6 430
+16%
|
6 362
-1%
|
7 483
+18%
|
9 873
+32%
|
11 474
+16%
|
15 146
+32%
|
15 976
+5%
|
|
Total Liabilities & Equity |
3 830
N/A
|
7 730
+102%
|
9 500
+23%
|
12 791
+35%
|
15 113
+18%
|
15 926
+5%
|
18 157
+14%
|
20 699
+14%
|
24 484
+18%
|
25 022
+2%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
1 624
|
1 744
|
1 782
|
1 782
|
1 782
|
1 769
|
1 792
|
1 787
|
1 851
|
1 846
|